Sai Life Sciences (NSE:SAILIFE) Notes Receivable: ₹0 Mil (As of Mar. 2026)


NSE:SAILIFE Sai Life Sciences Ltd NSE:SAILIFE
30 GF Score
Price ₹1,208.60
! 5 Warning Signs
View Full Analysis

What is Sai Life Sciences Notes Receivable?

Sai Life Sciences NSE:SAILIFE -1.95% 30 Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:SAILIFE with a GF Score™ of 30/100. The stock has 5 warning signs investors should review.

Sai Life Sciences's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0 Mil.

Sai Life Sciences Notes Receivable Related Terms

Sai Life Sciences Notes Receivable Historical Data

* Premium members only.

The historical data trend for Sai Life Sciences's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sai Life Sciences Notes Receivable Chart

Sai Life Sciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Sai Life Sciences Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:SAILIFE
30GF Score
Sai Life Sciences Ltd NSE:SAILIFE
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sai Life Sciences Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Sai Life Sciences (NSE:SAILIFE) has a Notes Receivable of ₹0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Sai Life Sciences and its competitors.
Is Sai Life Sciences' Notes Receivable too high?
Sai Life Sciences' current Notes Receivable is ₹0 Mil. Overall, Sai Life Sciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' Notes Receivable compare to TMO and DHR?
Sai Life Sciences' Notes Receivable of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Diagnostics & Research company?
A good Notes Receivable depends on the Medical Diagnostics & Research industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Sai Life Sciences and its competitors. Sai Life Sciences's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (NSE:SAILIFE) has a current Notes Receivable of ₹0 Mil. The current Notes Receivable is ₹0 Mil. Sai Life Sciences' overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Sai Life Sciences (NSE:SAILIFE), the current Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sai Life Sciences Business Description

Other Exchanges 544306:India
Address Gachibowli Miyapur Road, L4- 01 & 02, SLN Terminus Survey, Survey no. 133, Gachibowli, Hyderabad, TG, IND, 500032
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
30GF Score

Get the complete analysis for NSE:SAILIFE

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,208.60
Price